https://scholars.lib.ntu.edu.tw/handle/123456789/457783
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHENG-MAW HO | en_US |
dc.contributor.author | PO-HUANG LEE | en_US |
dc.contributor.author | CHI-LING CHEN | en_US |
dc.contributor.author | MING-CHIH HO | en_US |
dc.contributor.author | YAO-MING WU | en_US |
dc.contributor.author | REY-HENG HU | en_US |
dc.creator | Hu R.-H.;Wu Y.-M.;Ho M.-C.;Chen C.-L.;Lee P.-H.;CHENG-MAW HO | - |
dc.date.accessioned | 2020-02-11T03:53:59Z | - |
dc.date.available | 2020-02-11T03:53:59Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1068-9265 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862241705&doi=10.1245%2fs10434-011-1975-x&partnerID=40&md5=602d8c56983675cf0aa38c33ea45bc97 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/457783 | - |
dc.description.abstract | Purpose. We compared the long-term outcomes of resection and transplantation for hepatocellular carcinoma (HCC) while satisfying the University of California at San Francisco criteria. Methods. HCC patients who underwent liver resection (n = 746) and transplantation (n = 54) between 2001 and 2007 were reviewed. Overall and disease-free survival rates were evaluated using the Kaplan-Meier estimator, and independent prognostic factors were determined using the Cox proportional regression model. The presence of cirrhosis was used to divide the patients into groups. The patients who received primary transplantation were further analyzed. Results. Nine years after surgery, the patients' overall survival was similar in the resection and transplantation groups (75.9 and 77.2%, respectively). Furthermore, the recurrence rate in the resection group was higher than that in the transplantation group (65 vs. 34.4%; adjusted hazard ratio, 3.27; range, 1.76-6.08), especially for cirrhosis patients (adjusted hazard ratio, 4.28; range, 2.14-8.56). The results suggested that noncirrhotic patients who underwent resection had a better survival advantage than primary liver transplant recipients did (adjusted hazard ratio, 0.46; range, 0.18-1.21). However, noncirrhotic patients had higher recurrence rates (59.2 vs. 15.8%; adjusted hazard ratio, 3.98; range, 1.26-12.58). Similar trends were noted in patients with hepatitis B virus infection and/or a single tumor. Conclusions. Long-term survival rates after liver transplantation and resection were similar, but the latter was associated with a higher recurrence rate. ? Society of Surgical Oncology 2011. | - |
dc.relation.ispartof | Annals of Surgical Oncology | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | alpha fetoprotein; mycophenolic acid 2 morpholinoethyl ester; prednisolone; adult; article; cancer prognosis; cancer recurrence; cancer size; cancer surgery; cancer survival; comparative study; diagnostic imaging; disease classification; disease free survival; female; follow up; hepatitis B; human; immunosuppressive treatment; liver cell carcinoma; liver cirrhosis; liver resection; liver transplantation; liver tumor; major clinical study; male; metastasis; outcome assessment; overall survival; proportional hazards model; recurrence risk; scoring system; University of California at San Francisco criteria; liver cell carcinoma; liver cirrhosis; liver tumor; middle aged; mortality; pathology; prognosis; survival rate; tumor recurrence; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate | - |
dc.title | Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1245/s10434-011-1975-x | - |
dc.identifier.pmid | 21879276 | - |
dc.identifier.scopus | 2-s2.0-84862241705 | - |
dc.relation.pages | 826-833 | - |
dc.relation.journalvolume | 19 | - |
dc.relation.journalissue | 3 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUHBH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.dept | Surgery-NTUCC | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.orcid | 0000-0003-1874-7615 | - |
crisitem.author.orcid | 0000-0001-5831-035X | - |
crisitem.author.orcid | 0000-0003-3660-1062 | - |
crisitem.author.orcid | 0000-0002-1720-7863 | - |
crisitem.author.orcid | 0000-0001-6709-031X | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital Bei-Hu Branch | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。